When an IPO happens, headlines usually focus on the issue size, price band, subscription numbers and listing expectations. However, the Symbiotec Pharmalab IPO offers another interesting story: the investors who backed the company before it reached the public markets and the wealth their investments have created. The PrivateCircle data highlights three key investors InvAscent, Motilal…
Read more
When an IPO happens, headlines usually focus on listing gains and subscription numbers. However, the real story often lies elsewhere, in the wealth-creation journey of early investors who patiently backed the company long before public markets opened. The IPO of Sedemac Mechatronics Limited offers exactly that lens. From institutional funds to family trusts and even…
Read more
A Deep Dive Into Value Unlock, Investor Journeys & Market Timing The NephroPlus IPO has arrived with remarkable buzz. And understandably so. After all, this isn’t merely another healthcare listing; rather, it’s the culmination of a decade-long journey powered by patient capital, strategic partnerships, and consistent scale-up. Moreover, the Offer for Sale (OFS) attached to…
Read more